Tatsuya Ishibashi

Myotonic dystrophy type 1 with diabetes mellitus, mixed hypogonadism and adrenal insufficiency

Ken Takeshima, Hiroyuki Ariyasu, Tatsuya Ishibashi et al. · Endocrinology Diabetes and Metabolism Case Reports · 2018 · 17 citations · Full text

Nicotinic acetylcholine receptor signaling regulates inositol‐requiring enzyme 1α activation to protect β‐cells against terminal unfolded protein response under irremediable endoplasmic reticulum stress

Tatsuya Ishibashi, Shuhei Morita, Shohei Kishimoto et al. · Journal of Diabetes Investigation · 2020 · 15 citations · Full text

Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib

Yusuke Yamashita, Shuhei Morita, Hiroki Hosoi et al. · International Journal of Molecular Sciences · 2020 · 15 citations · Full text

Renoprotective potential of concomittant medications with SGLT2 inhibitors and renin-angiotensin system inhibitors in diabetic nephropathy without albuminuria: a retrospective cohort study

Tatsuya Ishibashi, Shuhei Morita, Hiroto Furuta et al. · Scientific Reports · 2023 · 14 citations · Full text

Thyroid function, glycemic control, and diabetic nephropathy in patients with type 2 diabetes over 24 months: prospective observational study

Hiroshi Iwakura, Tomoyuki Takagi, Hidefumi Inaba et al. · BMC Endocrine Disorders · 2023 · 12 citations · Full text